The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

18 March 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

66827 result(s) found, displaying 276 to 300

VENLAFAXINE ALEM XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALEM XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALEMBIC XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALEMBIC XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALEMBIC XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALEMBIC XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALMA XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALMA XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALMA XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALMA XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALSA XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALSA XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALSA XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE ALSA XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE APAL XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE APAL XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE APAL XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE APAL XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE APEL XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE APEL XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE APEL XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE APEL XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE APGH XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE APGH XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VENLAFAXINE APGH XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

3 March 2025

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd

Last updated

18 March 2025

Sub menu

Cancellations by sponsors

Filter results

VENLAFAXINE ALEM XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALEM XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALEMBIC XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALEMBIC XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALEMBIC XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALEMBIC XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALMA XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALMA XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALMA XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALMA XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALSA XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALSA XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALSA XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE ALSA XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE APAL XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE APAL XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE APAL XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE APAL XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE APEL XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE APEL XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE APEL XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE APEL XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE APGH XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE APGH XR venlafaxine (as hydrochloride) 225 mg modified release capsule Cancelled under Section 30(1)(c) of the Act

VENLAFAXINE APGH XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

Help us improve this page

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Help us improve this page